Stock listing

Euronext:ALIKO Ikonisys SA Action

Home listing (Euronext) of Ikonisys SA

Follow Ikonisys SA into a list and get an email when it puts out news.

Share price · EURONEXT:ALIKO

€1.42 EUR -0.01 (-0.7%)

Close on Oct 30, 2026

Past year -3.4% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
€1.42 – €1.42 EUROct 30, 2026
Volume
44 sharesOct 30, 2026
Market cap
€22.47M EURAt the close on Oct 30, 2026 · price × 15.83M shares outstanding
52-week range
€1.30 – €1.84 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
€3,762 EURMedian day 1,791 shares · 4 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Ikonisys SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALIKO · Home€1.42 EUR-0.01 (-0.7%)44€1.42€1.42€1.42€1.43Close on Oct 30, 2026
Frankfurt:9W8€1.35 EUR+0.06 (+4.7%)—€1.35€1.35€1.35€1.29Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:ALIKO · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.42-0.01-0.7%€1.42€1.42€1.4244
€1.43+0.03+2.1%€1.40€1.45€1.403,334
€1.40+0.07+5.3%€1.35€1.41€1.351,947
€1.33-0.05-3.6%€1.36€1.36€1.336,542
€1.38+0.01+0.7%€1.37€1.39€1.362,521
€1.37-0.01-0.7%€1.37€1.37€1.37168
€1.38-0.03-2.1%€1.35€1.41€1.351,482
€1.410.000.0%€1.40€1.41€1.352,314
€1.41-0.02-1.4%€1.43€1.43€1.361,777
€1.430.000.0%€1.41€1.43€1.41349
€1.43+0.02+1.4%€1.43€1.43€1.4310
€1.410.000.0%€1.42€1.42€1.41190
€1.41-0.03-2.1%€1.42€1.42€1.41190
€1.44+0.02+1.4%€1.42€1.44€1.42303
€1.42+0.02+1.4%€1.42€1.42€1.42445
€1.40-0.04-2.8%€1.42€1.42€1.402,001
€1.44+0.01+0.7%€1.42€1.44€1.42305
€1.43-0.01-0.7%€1.43€1.43€1.431,010
€1.44-0.01-0.7%€1.44€1.45€1.434,177
€1.45-0.02-1.4%€1.46€1.46€1.443,288
€1.47+0.02+1.4%€1.44€1.47€1.4011,547
€1.45+0.05+3.6%€1.40€1.45€1.3513,490
€1.40-0.01-0.7%€1.41€1.41€1.403,136
€1.41-0.02-1.4%€1.42€1.42€1.412,689
€1.43+0.01+0.7%€1.42€1.43€1.42810
€1.420.000.0%€1.41€1.43€1.415,112
€1.42+0.01+0.7%€1.41€1.42€1.41569
€1.41-0.01-0.7%€1.41€1.41€1.41205
€1.420.000.0%€1.41€1.42€1.411,079
€1.42+0.04+2.9%€1.40€1.42€1.405,931
€1.38-0.02-1.4%€1.39€1.39€1.381,791
€1.400.000.0%€1.39€1.40€1.382,144
€1.400.000.0%€1.39€1.40€1.391,401
€1.400.000.0%€1.40€1.40€1.309,339
€1.400.000.0%€1.36€1.40€1.364,685
€1.400.000.0%€1.36€1.40€1.364,685
€1.400.000.0%€1.38€1.40€1.342,690
€1.400.000.0%€1.42€1.42€1.40244
€1.40-0.02-1.4%€1.42€1.42€1.40244
€1.42+0.02+1.4%€1.42€1.42€1.422,500
€1.40-0.02-1.4%€1.40€1.40€1.405,201
€1.420.000.0%€1.42€1.42€1.418,028
€1.42-0.06-4.1%€1.48€1.48€1.409,005
€1.48-0.04-2.6%€1.50€1.50€1.48347
€1.52+0.06+4.1%€1.46€1.52€1.464,595
€1.46-0.02-1.4%€1.46€1.46€1.46377
€1.48+0.02+1.4%€1.46€1.48€1.46514
€1.46+0.04+2.8%€1.42€1.46€1.422,737
€1.42-0.04-2.7%€1.44€1.44€1.404,735
€1.46-0.08-5.2%€1.52€1.52€1.424,146
€1.54+0.02+1.3%€1.54€1.54€1.52278
€1.520.000.0%€1.54€1.54€1.505,217
€1.52+0.06+4.1%€1.44€1.58€1.449,614
€1.460.000.0%€1.46€1.46€1.4669
€1.46+0.04+2.8%€1.42€1.48€1.423,434
€1.42-0.02-1.4%€1.42€1.42€1.4299
€1.44+0.02+1.4%€1.42€1.44€1.40461
€1.42-0.04-2.7%€1.44€1.44€1.421,000
€1.460.000.0%€1.46€1.46€1.4625
€1.46+0.01+0.7%€1.46€1.46€1.46184
€1.45-0.01-0.7%€1.47€1.47€1.441,975
€1.46+0.06+4.3%€1.40€1.46€1.403,314
€1.40-0.10-6.7%€1.46€1.46€1.403,937
€1.500.000.0%€1.54€1.54€1.490
€1.500.000.0%€1.54€1.54€1.490
€1.500.000.0%€1.54€1.54€1.490
€1.500.000.0%€1.54€1.54€1.490
Ticker
Euronext:ALIKO
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD 2 Million

Sep 21, 2026

Closed €1.42 (+2.9%) on Sep 21, 2026

Aliko Scientific Launches Probantes in Brazil and Establishes a New Molecular Diagnostic Development and Commercial Platform for South America

Sep 15, 2026

Closed €1.40 (0.0%) on Sep 15, 2026

Aliko Scientific Successfully Launches U.S. Business Development Collaboration With Partner International at ADLM 2026, the World’s Largest Molecular Diagnostics Exhibition

Sep 7, 2026

Closed €1.40 (-1.4%) on Sep 8, 2026

Aliko Scientific Provides a Financial Update Following the Publication of its FY 2025 Results and Reaffirms Its Business Momentum

Aug 24, 2026

Closed €1.42 (-2.7%) on Aug 25, 2026

Aliko Scientific Signs New Distribution Agreements in Romania and Saudi Arabia, Strengthening Its International Commercial Network

Aug 5, 2026

Closed €1.46 (+4.3%) on Aug 6, 2026

Ikonisys SA Reports its Full-Year Financial Results for 2025 and Provides an Update on Its Latest Developments

Jul 30, 2026

Closed €1.50 (0.0%) on Jul 31, 2026

Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project

Jul 23, 2026

Closed €1.50 (0.0%) on Jul 23, 2026

Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture

May 25, 2026

Closed €1.55 (0.0%) on May 26, 2026

Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital

May 19, 2026

Closed €1.58 (+3.9%) on May 20, 2026

Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona

May 11, 2026

Closed €1.38 (-1.4%) on May 12, 2026

Issued by another party

All Ikonisys SA news

Financings

  • Convertible notes

    Aug 24, 2026 · US$842,864

    Closed: €722,500 raised

    Use of proceeds: Strengthen the Group's available liquidity

    Closed Aug 24, 2026

Read by 6ix AI from the company's releases

Ikonisys SA on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
20 in the last 12 months · 28 in all · newest Sep 21, 2026 · oldest 2025

Where Ikonisys SA is listed

ListingExchangeCountryCurrency
Euronext:ALIKO · Home listing · This pageEuronextFranceEUR
LS Exchange:A3CVR6LS ExchangeGermanyEUR
Frankfurt:9W8FrankfurtGermanyEUR
Lang & Schwarz:A3CVR6Lang & SchwarzGermanyEUR
Stuttgart:9W8StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Ikonisys SA.